The in vivo properties of pagoclone in rat are most likely mediated by 5′-hydroxy pagoclone

This publication has 39 references indexed in Scilit:

• TPA023 [7-(1,1-Dimethylethyl)-6-(2-ethyl-2 H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an Agonist Selective for α2- and α3-Containing GABAA Receptors, Is a Nonsedating Anxiolytic in Rodents and Primates
  The Journal of Pharmacology and Experimental Therapeutics, 2006
• The benzodiazepine binding site of GABA_Areceptors as a target for the development of novel anxiolytics
  Expert Opinion on Investigational Drugs, 2005
• Anxiogenic properties of an inverse agonist selective for α3 subunit‐containing GABA_A receptors
  British Journal of Pharmacology, 2005
• Pharmacological characterization of a novel cell line expressing human α₄β₃δ GABA_A receptors
  British Journal of Pharmacology, 2002
• Cognitive and Sedative Effects of Benzodiazepine Use
  Current Pharmaceutical Design, 2002
• The use of benzodiazepines in anxiety and other disorders
  European Neuropsychopharmacology, 1999
• Regional Differences in the Inhibition of Mouse In Vivo [3H]Ro 15-1788 Binding Reflect Selectivity for α1 versus α2 and α3 Subunit-Containing GABAA Receptors
  Neuropsychopharmacology, 1999
• Comparison of benzodiazepine (BZ) receptor agonists in two rodent activity tests
  Journal of Psychopharmacology, 1996
• Ligands for benzodiazepine receptors with positive and negative efficacy
  Biochemical Pharmacology, 1984
• Suriclone: A New Cyclopyrrolone Derivative Recognizing Receptors Labeled by Benzodiazepines in Rat Hippocampus and Cerebellum
  Journal of Neurochemistry, 1983